The 41 references in paper L. Shalkevich V., A. Kudlach I., O. Nazarova P., Л. Шалькевич В., А. Кудлач И., О. Назарова П. (2017) “Влияние гормонов гипоталамо-гипофизарно-надпочечниковой системы на процессы эпилептогенеза // THE IMPACT OF H YPOTHALAMIC-PITUITARY-ADRENAL SYSTEM HORMONES ON EPILEPTOGENESIS” / spz:neicon:rjdn:y:2017:i:1:p:47-55

1
Айвазян С.О., Лукьянова Е.Г., Ширя- ев Ю.С. Современные возможности лечения фармакорезистентной эпилепсии у детей. Эпилепсия и пароксизмальные состояния 2014;6(1):34–43. [Ayvazyan S.O., Luk’yanova E.G., Shiryaev Yu.S. Modern treatment options for drug-resistant epilepsy in children. Epilepsiya i paroksizmal’nye sostoyaniya = Epilepsy and Paroxysmal States 2014;6(1):34–43. (In Russ.)].
(check this in PDF content)
2
Звонкова Н.Г., Балканская С.В., Каркашадзе М.З. и др. Альтернативные методы лечения эпилепсии у детей. Вопросы современной педиатрии 2005;4(4):28–32. [Zvonkova N.G., Balkanskaya S.V., Karkashadze M.Z. et al. Alternative methods of treatment of epilepsy in children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2005;4(4): 28–32. (In Russ.)].
(check this in PDF content)
3
Мухин К.Ю., Петрухин А.С., Холин А.А. Эпилептические энцефалопатии и схожие синдромы у детей. М.: АртСервис Лтд, 2011. 680 с. [Mukhin K.Yu., Petrukhin A.S., Kholin A.A. Epileptic encephalopaties and similar syndromes in children. Moscow: ArtService Ltd, 2011. 680 p. (In Russ.)].
(check this in PDF content)
4
Студеникин В.М., Звонкова Н.Г., Боровик Т.Э. и др. Кетогенная диета при эпилепсии у детей. Вопросы современной педиатрии 2004;1(3): 47–52. [Studenikin V.M., Zvonkova N.G., Borovik T.E. et al. Ketogenic diet in epileptic children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2004;1(3):47–52. (In Russ.)].
(check this in PDF content)
5
Физиология эндокринной системы. Пер. с англ. Под ред. Дж. Гриффина, С. Охеды. М.: Бином. Лаборатория знаний, 2008. 496 с. [Physiology of the endocrine system. Transl. from Engl. Eds. by J. Griffin, S. Ojeda. Moscow: Binom. Laboratoriya znanii, 2008. 496 p. (In Russ.)].
(check this in PDF content)
6
Шалькевич Л.В., Шанько Г.Г., Кот Д.А. Кортикостероидная терапия фармакорезистентных эпилепсий у детей. Международный неврологический журнал 2014;3(65):20–7. [Shal’kevich L.V., Shan’ko G.G., Kot D.A. Corticosteroid therapy of drug-resistant epilepsies in children. Mezhdunarodnyy nevrologicheskiy zhurnal = International Neurological Journal 2014;3(65):20–7. (In Russ.)].
(check this in PDF content)
7
Aicardi J. Clinical approach to the management of intractable epilepsy. Dev Med Child Neurol 1988;30:429–40. PMID: 3049187.
(check this in PDF content)
8
Aldenhoff J.B., Gruol D.L., Rivier J. et al. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 1983;221(4613):875–7. PMID: 6603658.
(check this in PDF content)
9
Ardeleanu A., Sterescu N. RNA and DNA synthesis in developing rat brain: hormonal influences. Psychoneuroendocrinol 1978;3(1):93–101. PMID: 2055895.
(check this in PDF content)
10
Avishai-Eliner S., Yi S.J., Baram T.Z. Developmental profile of messenger RNA for corticotropin-releasing hormone in the rat limbic system. Brain Res Dev Brain Res 1996;91(2):159–63. PMID: 8852365.
(check this in PDF content)
11
Baram T.Z., Hatalski C.G. Neuropeptidemediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21(11):471–6. PMID: 9829688.
(check this in PDF content)
12
Brunson K.L., Avishai-Eliner S., Baram T.Z. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49:185–97. PMID: 12040892.
(check this in PDF content)
13
Dumermuth G. Uber die Blitz-Nick-Salaam-Krampfe und ihre Behandlung mit ACTH und hydrocortison. Vorlaufige Mitteilung. Helv Paediatr Acta 1959;14:250–70. PMID: 13818581.
(check this in PDF content)
14
Dunwiddie T.V., Fredholm B.B. Adenosine neuromodulation. In: Purinergic approaches in experimental therapeutics. Eds. by K.A. Jacobson, M.F. Jarvis. New York: Wiley Liss, 1997. Pp. 359–382.
(check this in PDF content)
15
Gastaut H., Saltiel J., Raybaud C. et al. A propos du traitement par l’ACTH des encephalites myoclonique de la premiere enfance avec majeure (hypsarhythmia). Pediatrie 1959;14(1):35–41. PMID: 13633380.
(check this in PDF content)
16
Giorgi F.S., Pizzanelli C., Biagioni F. et al. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev 2004;28(5):507–24. DOI: 10.1016/j.neubiorev.2004.06.008. PMID: 15465138.
(check this in PDF content)
17
Haas H.L., Greene R.W. Endogenous adenosine inhibits hyppocampal CA1 neurones: further evidence from extra- and intracellular recording. Naunyn-Schmiedeberg’s Arch Pharmacol 1988;337(5):561–5. PMID: 3412493.
(check this in PDF content)
18
Hollrigel G.S., Chen K., Baram T.Z. et al. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neurosci 1998;84(1):71–9. PMID: 9522363.
(check this in PDF content)
19
Huttenlocher P.R., Amemiya I.M. Effect of adrenocortical steroids and of adrenocorticotrophic hormone on (Na+/K+)ATP-ase in immature cerebral cortex. Pediatr Res 1978;12(2):104–7. DOI: 10.1203/00006450-197802000-00008. PMID: 205825.
(check this in PDF content)
20
Iacobas D.A., Iacobas S., Chachua T. et al. Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms. J Neuroendocrinol 2013;25(11):964–79. DOI: 10.1111/jne.12061. PMID: 23763471.
(check this in PDF content)
21
Irani S.R., Buckley C., Vincent A. et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008;71(20):1647–8. DOI: 10.1212/01.wnl.0000326572.93762.51. PMID: 18815385.
(check this in PDF content)
22
Jarvis M.F., Williams M. Adenosine in central nervous system function. In: Adenosine and adenosine receptors. Ed. by M. Williams. Clifton: The Humana Press, 1990. Pp. 423–474.
(check this in PDF content)
23
Klein R., Livingston S. The effect of adrenocorticotrophic hormones in epilepsy. J Pediatr 1950;37(5):733–42. PMID: 14784927.
(check this in PDF content)
24
Low N.L. Infantile spasms with mental retardation. II. Treatment with cortisone and adrenocorticotropin. Pediatrics 1958;22(6):1165–9. PMID: 13613851.
(check this in PDF content)
25
Marver D. Evidence of corticosteroid action along the nephron. Am J Physiol 1984;246(2):111–23. PMID: 6320678.
(check this in PDF content)
26
McKnight K., Jiang Y., Hart Y. et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurol 2005;65(11):1730–6. DOI: 10.1212/01.wnl.0000187129.66353.13. PMID: 16344514.
(check this in PDF content)
27
McQuarrie I., Anderson J.A., Ziegler M.R. Observation on the antagonistic effects of posterior pituitary and cortico-adrenal hormones in the epileptic subject. J Clin Endocrinol 1942;2: 406–10.
(check this in PDF content)
28
Munakata M. et al. Reduction in glutamine/glutamate levels in the cerebral cortex after adrenocorticotropic hormone therapy in patients with West syndrome. Tohoku J Exp Med 2014;232(4):277–83. PMID: 24705707.
(check this in PDF content)
29
Molteni R., Fumagalli F., Magnaghi V. et al. Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res Brain Res Rev 2001;37 (1–3):249–58. PMID: 11744090.
(check this in PDF content)
30
O’Regan M.E., Brown J.K. Is ACTH a key to understanding anticonvulsant action? Dev Med Child Neurol 1998;40(2):82–9. PMID: 9489495.
(check this in PDF content)
31
Palo J., Savolainen H. The effect of high doses of synthetic ACTH on rat brain. Brain Res 1974;70(2):313–20. PMID: 4363491.
(check this in PDF content)
32
Prazantelli M.R. On the molecular mechanism of adrenocorticotropic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125(1):142–61. DOI: 10.1006/exnr.1994.1018. PMID: 7905835.
(check this in PDF content)
33
Riikonen M.R., Soderstrom S., Vanhala R. et al. West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 1997;17(3):224–9. PMID: 9390698.
(check this in PDF content)
34
Sorel L., Dusaucy-Bauloye A. A propos de 21 cas d’hypsarhythmie de Gibbs: son traitement spectaculaire par I'ACTH. Acta Neurol Psychiatr Belg 1958;58(2):130. PMID: 13532578.
(check this in PDF content)
35
Stamps F.W., Gibbs E.L., Rosenthal I.M. et al. Treatment of hypsarrhythmia with ACTH. J Am Med Assoc 1959;171: 408–11. PMID: 13833723.
(check this in PDF content)
36
Storm van Leeuwen W., Lopes da Silva F.H., de Weid D. A frequency shift in the hippocampal teta activity: an electrical correlate of central action of ACTH analogues in the dog? Brain Res 1974;69(2):361–5. PMID: 4362816.
(check this in PDF content)
37
Urban I., de Weid D. Changes in excitability of the theta generating substrate by ACTH 4–10 in the rat. Exp Brain Res 1976;24:325–34. PMID: 176046.
(check this in PDF content)
38
Vaughan C.J., Delanty N. Pathophysiology of acute symptomatic seizures. In: Seizures: Medical Causes and Management. Ed. by N. Delanty. The Humana Press: Totowa, NJ, 2002. Pp. 7–24.
(check this in PDF content)
39
Vreugdenhil E., de Kloet E.R., Schaaf M. et al. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol 2001;11(6):423–30. PMID: 11704419.
(check this in PDF content)
40
Weissmann G., Thomas L. Studies on lysosomes. II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A. J Clin Invest 1963;42(5):661–9. DOI: 10.1172/JCI104757. PMID: 13999782.
(check this in PDF content)
41
Zhang Y., Zou L.P., Ding Y.X. et al. Association of SCN1A gene polymorphisms with infantile spasms and adrenocorticotropic hormone responsiveness. Eur Rev Med Pharmacol Sci 2014;18(17):2500–6.
(check this in PDF content)